SPR Therapeutics, a medical device company, has raised $5 million in the initial phase of financing for the commercialization of pain therapies using its proprietary peripheral nerve stimulation technology, according to a peHUB report.
SPR Therapeutics has developed devices and technologies, such as the Micropulse investigational pain therapy device, to address acute and chronic joint pain disorders. SPR's therapies use a method of peripheral nerve stimulation to treat pain, where electrodes are positions in proximity to but not directly contacting peripheral nerves.
Indiana State Senator Drafts Legislation to Restrict Opioid Prescriptions
Prospira PainCare Acquires National Pain Institute
SPR Therapeutics has developed devices and technologies, such as the Micropulse investigational pain therapy device, to address acute and chronic joint pain disorders. SPR's therapies use a method of peripheral nerve stimulation to treat pain, where electrodes are positions in proximity to but not directly contacting peripheral nerves.
More Articles on Pain Management:
New Pain Management Center Opens in VirginiaIndiana State Senator Drafts Legislation to Restrict Opioid Prescriptions
Prospira PainCare Acquires National Pain Institute